Detalles de la búsqueda
1.
Nonclinical Efficacy and Safety of CX-2029, an Anti-CD71 Probody-Drug Conjugate.
Mol Cancer Ther
; 21(8): 1326-1336, 2022 08 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35666803
2.
Inhibition of V3-specific cleavage of recombinant HIV-1 gp120 produced in Chinese hamster ovary cells.
Protein Expr Purif
; 59(2): 223-31, 2008 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-18406166
3.
Immunosuppressive effect of ASP2408, a novel CD86-selective variant of CTLA4-Ig, in rats and cynomolgus monkeys.
Int Immunopharmacol
; 40: 310-317, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27662596
4.
ASP2408 and ASP2409, novel CTLA4-Ig variants with CD86-selective ligand binding activity and improved immunosuppressive potency, created by directed evolution.
Protein Eng Des Sel
; 29(5): 159-67, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26968452
5.
The Effect of ASP2409, a Novel CD86-Selective Variant of CTLA4-Ig, on Renal Allograft Rejection in Nonhuman Primates.
Transplantation
; 100(12): 2611-2620, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27861289
6.
Directed evolution of gene-shuffled IFN-alpha molecules with activity profiles tailored for treatment of chronic viral diseases.
Proc Natl Acad Sci U S A
; 104(20): 8269-74, 2007 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17494769
7.
Testis-specific TAF homologs collaborate to control a tissue-specific transcription program.
Development
; 131(21): 5297-308, 2004 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-15456720
Resultados
1 -
7
de 7
1
Próxima >
>>